Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline (TMC207) in MDR-TB
NCT00449644Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of bedaquiline in Tuberculosis (TB), sponsored by Johnson & Johnson. Started Jun 2007; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00449644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449644.